Section navigation

Middlesex leads EU-funded drugs research

21/03/2017
Middlesex criminology and mental health academics lead the way in developing drug prevention for young people in criminal justice systems

EU flagMiddlesex University is coordinating an EU funded Health Programme project* to investigate the best drug prevention practices for young people who are in contact with criminal justice systems across Europe. The project is supported by CHAFEA (Consumers, Health, Agriculture and Food Executive Agency) and will run from 2017 until December 2019.

Young offenders are considered one of the most vulnerable or at risk groups of developing drug problems and are often affected by numerous health and social inequalities.

Led by Professor Betsy Thom and Dr Karen Duke of Middlesex University’s Drug and Alcohol Research Centre (DARC), researchers will identify innovative prevention projects, collect new information and examine the views of young people and service providers on prevention approaches for this target group.

“Our main aim is to find out what interventions across Europe work in preventing and reducing drug use in young people within criminal justice systems,” says Dr Karen Duke, who is also an Associate Professor in Criminology at Middlesex.

“Alongside this we will be examining the effectiveness of current European drug prevention quality standards for our target group and facilitating collaboration and knowledge exchange across countries.”

A growing community of research excellence, Middlesex University has become renowned for its ground breaking, innovative research that makes a real difference in the world.

Learn more about how Middlesex University produces research with real impact

EPPIC logo EU logo
















*Partner universities include: Change Grow Live (UK), Aarhus University (DK), Eclectica (IT), European Centre for Social Welfare Policy and Research (AT), Frankfurt University of Applied Sciences (DE), Institute of Psychiatry and Neurology (PL).

Picture attribution: CC 2:0 Rock Cohen

Comments (0)


Leave your comment

In this section

Back to top

We use Cookies

View our Privacy and Cookie policy

Continue